Gilead signs licenses for generic companies to make and sell remdesivir in 127 countries
Seeking to blunt concerns about access to its remdesivir treatment for Covid-19, Gilead Sciences (GILD)…
Category: Biotech
.jpg)
STAT Plus: Deluge of genome editing therapies end research drought for sickle cell disease
The newest publicly traded genome editing company, Beam Therapeutics, has gotten one of its experimental…
STAT Plus: Trump administration proposes a dramatic payment boost for CAR-T treatments under Medicare
WASHINGTON — The Centers for Medicare and Medicaid Services proposed a major payment bump for…
6 takeaways from the Senate’s surreal virtual hearing on the U.S. coronavirus response
WASHINGTON — The Senate’s first major hearing on the Covid-19 pandemic began with the sounds…
STAT Plus: Pharmalittle: Birx acknowledges remdesivir distribution was flawed; Moderna gets FDA fast track for Covid-19 vaccine
Top of the morning to you, and a fine one it is. Despite the doom…
Digital event: Confronting a Pandemic — Part 2
Editor’s note: The livestream will be embedded below at 1 p.m. ET. The need to…
Opinion: Lead aprons offer little protection during X-rays. Why do so many clinicians keep using them?
Think back to the last time you had an X-ray: The technician probably placed a…
Opinion: Waiting for my daughter Blueberry in the Year Zero of Covid-19
Medicine is typically an intimate interaction with its one-on-one conversations and physical exams behind closed…
Opinion: To put Covid-19 behind us, all Americans should be vaccinated against it
My work as an emergency medicine physician has taken me to urban and rural areas…
With little data, doctors struggle to decide which Covid-19 patients should get remdesivir
Now that the federal government has begun distributing the experimental Covid-19 drug remdesivir, hospitals are…
STAT Plus: With hopes running high for Moderna’s coronavirus vaccine, the stock’s value requires an almost mythical leap of faith
Moderna is moving at unprecedented speed to develop a vaccine to prevent infection from the…
Covid-19 has streamlined addiction medicine. Will the changes stick?
Nicole Godinez’s monthly visit to an addiction clinic typically takes several hours: To start, there’s…
A secret experiment revealed: In a medical first, doctors treat Parkinson’s with a novel brain cell transplant
A month before the scheduled surgery, the four researchers were ready to chaperone the brain…
French drug maker Genfit says NASH drug fails late-stage clinical trial
French drug maker Genfit said Monday that its lead drug, elafibranor, failed to improve outcomes…
STAT Plus: Prominent Broad Institute scientist leaves to lead R&D at Genentech
A star scientist in the world of single-cell genomics and computational biology is leaving academia…
New research sheds light on sex imbalances in diseases like schizophrenia and lupus
There’s a clear sex bias in many diseases. Lupus, for instance, affects women nine times…
STAT Plus: Pharmalittle: Hackers linked to Iran sought Gilead Covid-19 data; NIH to test remdesivir with a Lilly drug
Hello, everyone, and welcome to another working week. We hope the weekend respite was sufficiently…
STAT Plus: Hospitals are reluctant to share data. A new effort to map brain tumors with AI is getting their help another way
It’s a contradiction that’s long slowed the forward march of artificial intelligence in medicine: Machine…
STAT Plus: Results indicate MyoKardia drug is a ‘potential game changer’ for heart condition
An experimental drug to treat an inherited, progressive heart disease clearly improved the symptoms of…
STAT Plus: Atul Gawande to depart as CEO of splashy health venture. Is it ‘a death knell’?
It seemed an ideal partnership: Three of America’s most powerful companies were teaming up with…
Opinion: A global pathogen shield: the health security step to ‘never again’
In the name of strategic defense, the world’s nations have amassed enough nuclear weapons to…
Opinion: Three traps for the unwary in HHS’ provider relief fund
In its rush to offer a lifeline to U.S. health care providers struggling under the…
14 questions for Fauci, Redfield, and the other Trump officials testifying on the U.S. coronavirus response
The Trump administration figures who’ve led the federal government’s coronavirus response have escaped the wrath…
Inside the NIH’s controversial decision to stop its big remdesivir study
The drug maker Gilead Sciences released a bombshell two weeks ago: A study conducted by…
Trump administration announces plan to distribute Covid-19 drug amid concerns over allocation
WASHINGTON — The federal government on Saturday announced a plan to distribute remdesivir, the antiviral…
STAT Plus: A new Trump administration rule could increase out-of-pocket drug costs
Even as prescription drug costs remain an important pocketbook issue for many Americans, the Trump…
7 questions about Covid-19 testing and what it means for reopening the country
Pressure to perform widespread Covid-19 testing is growing as public health experts and ordinary citizens…
Routine vaccinations for U.S. children have plummeted during the Covid-19 pandemic
Routine vaccination of children in the United States appeared to have declined dramatically in March…
What the world learned in eradicating smallpox: Unity mattered
Forty years ago, the world celebrated the vanquishing of a formidable foe, smallpox, which had…
STAT Plus: Pharmalittle: Hydroxycholoroquine fails to help patients in a study; what will states do with the old malaria drug now?
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Maryland governor vetoes funding for a prescription drug affordability board
In a surprise move, Maryland Gov. Larry Hogan vetoed state funding for a “Prescription Drug…
Opinion: Acknowledging the public role in private drug development: lessons from remdesivir
The quest for vaccines and therapeutic treatments against Covid-19 shouldn’t be complicated or delayed by…
The U.S. government contributed research to a Gilead remdesivir patent — but didn’t get credit
Two documents dating back to 2015 shed further light on the role the federal government…
STAT Plus: Apotex to pay $24 million to settle price fixing charges stemming from long-running probe
In the latest fallout from a federal probe into generic drug price fixing, Apotex agreed…
Opinion: What the Covid-19 pandemic is teaching us about community
“There is no power for change greater than a community discovering what it cares about.”…
Opinion: Nursing homes, veterans’ homes are national epicenters of Covid-19
It is only Saturday afternoon and our emergency department has already seen the fourth patient…
STAT Plus: Dyne Therapeutics and three other startups got venture funding a year ago. Will it be enough to get them through Covid-19?
How a venture-backed startup gets its money is suddenly more fraught than it used to…
The porn industry tests and traces. Could it offer a model for reopening amid Covid-19?
LOS ANGELES — As states and employers furiously develop plans to safely reopen workplaces in…
STAT Plus: CytoDyn says lead HIV drug was not filed for FDA approval, as previously claimed
CytoDyn CEO Nader Pourhassan is already under fire for the timing of lucrative sales of…
STAT Plus: AI-centric health companies landed crucial funding in early 2020
Artificial intelligence-focused health care companies raised nearly $1 billion in funding in the first quarter…
Listen: How bad will the pandemic get? Plus: Gilead’s pricing dilemma and fighting Covid-19 in New York
What if the curve just stays flat? How much should a Covid-19 drug cost? And…
STAT Plus: Telehealth rules have shifted rapidly during the pandemic. Are the changes here to stay?
The Trump administration appears to be leaning in favor of permanently expanding telemedicine coverage as…
.jpg)
A snapshot of coronavirus in the U.S.: A high plateau of new cases portends more spread
For all the talk of a second wave of coronavirus cases hitting the United States…
Digital event: Confronting a Pandemic — Part 1
Editor’s note: The livesteam will be embedded below at 2:30 p.m. ET. The need to…
STAT Plus: Pharmalittle: Hospitals criticize feds over remdesivir supplies; Moderna starting mid-stage Covid-19 vaccine trials soon
Hello, everyone, and how are you today? We are doing just fine, thank you, given…
Opinion: Covid-19 has renewed America’s trust in its doctors. Will it fade when the pandemic is over?
I had a disturbing conversation with my younger sister about the public perception of doctors…
Opinion: Child abuse is one of many unseen harms from shutting down America’s schools
Tick tock, tick tock. In elementary school, my friend Krystal (not her real name) kept…
Photos: A peek inside one Boston hospital’s response to Covid-19
This is one in a series of reports from hospitals responding to the Covid-19 pandemic. When he…
Amazon lends its expertise — and its cash — to Covid-19 research
Shipping behemoth Amazon is increasingly throwing its weight into the pandemic response, sharing its staff’s…
Doctors lambaste federal process for distributing Covid-19 drug remdesivir
Hospitals and physicians around the country are sharply criticizing the federal government for the uneven…